Essential Partners’s Disc Medicine IRON Stock Holding History

Essential Partners’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$131	Sell	2 -3	-60%	-$227	﹤0.01%	2668
2026 Q2	$366	Buy	5 +1	+25%	+$69	﹤0.01%	2537
2026 Q1	$256	Hold	4	–	–	﹤0.01%	2576
2025 Q4	$318	Hold	4	–	–	﹤0.01%	2326
2025 Q3	$264	Hold	4	–	–	﹤0.01%	2349
2025 Q2	$212	Buy	+4	New	+$188	﹤0.01%	1929

Other funds holding IRON

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Downshift Financial Boulder, Colorado $232M AUM 12.86% 1-Year Est. Return

Essential Partners's IRON Position: Q3 2026 in Review

Essential Partners reduced its Disc Medicine (IRON) stake by 60% in Q3 2026, selling an estimated $227 and leaving 2 shares worth $131. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

Essential Partners first reported a position in IRON in Q2 2025 and has held it in 6 quarters since. The position peaked at $366 in Q2 2026. 5 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

Essential Partners held 2 shares of Disc Medicine worth $131 as of Q3 2026.
Essential Partners sold 3 Disc Medicine shares in Q3 2026, an estimated $227.
Disc Medicine made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2668 holding.
Essential Partners first reported a position in Disc Medicine in Q2 2025 and has held it in 6 quarters since.
Essential Partners's Disc Medicine position peaked at $366 in Q2 2026.
5 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.